Beta-blockers for heart failure with reduced, mid-range, and preserved ejection fraction: an individual patient-level analysis of double-blind randomized trialsJohn G.F. Cleland, Andrew J.S. Coats, Luís Manzano et al.|European Heart Journal|2017Cited by 643
Genetic basis of attention deficit and hyperactivityAnita Thapar, Richard Harrington, Jane Holmes et al.|The British Journal of Psychiatry|1999Cited by 401
Impact of Renal Impairment on Beta-Blocker Efficacy in Patients With Heart FailureDipak Kotecha, Andrew J.S. Coats, Simrat Gill et al.|Journal of the American College of Cardiology|2019Cited by 67
A phase II open label, randomised study of ipilimumab with temozolomide versus temozolomide alone after surgery and chemoradiotherapy in patients with recently diagnosed glioblastoma: the Ipi-Glio trial protocolNicholas F. Brown, Paul Mulholland, Stasya Ng et al.|BMC Cancer|2020Cited by 51